The finding that blockade of AR by somatic knockdown or antagonists reverse the androgen-elicited effects on melanoma cell locomotion and 3D models, further reinforce the role of receptor in the androgen signaling leading to melanoma aggressiveness. The gene discussed is AR; the disease is melanoma.